ASHLEY WONG: Open Payments
NPI 1275289324 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,895 in 131 payments from 24 companies in 2025. Trend: 2023 $2,317 · 2024 $2,916 · 2025 $2,895
Food & beverage: $2,895
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $548 |
| Janssen Biotech, Inc. | 20 | $548 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $320 |
| Madrigal Pharmaceuticals | 10 | $289 |
| Gilead Sciences, Inc. | 15 | $221 |
| Celltrion USA Inc. | 6 | $161 |
| Lilly USA, LLC | 10 | $154 |
| GENZYME CORPORATION | 4 | $91 |
| PFIZER INC. | 4 | $76 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, ENTYVIO, VEGZELMA, OMVOH, DUPIXENT, EOHILIA.
Industry payments across CO — which companies pay providers there.
